{
    "2021-04-26": [
        [
            {
                "time": "",
                "original_text": "康弘药业修正业绩报告亏损2.7亿，13亿研发费用打水漂！ 业绩更正",
                "features": {
                    "keywords": [
                        "康弘药业",
                        "业绩修正",
                        "亏损",
                        "研发费用"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "逆势大涨！这个行业迎重磅利好！",
                "features": {
                    "keywords": [
                        "逆势大涨",
                        "行业",
                        "重磅利好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "未明确"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "基金规模迎高速增长期 投研能力成基金公司发展基石",
                "features": {
                    "keywords": [
                        "基金规模",
                        "高速增长",
                        "投研能力",
                        "发展基石"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药股全面爆发！多股获明星基金提前加仓",
                "features": {
                    "keywords": [
                        "医药股",
                        "全面爆发",
                        "明星基金",
                        "加仓"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "需求旺盛创新加码 美年健康夯实内功迎高质量发展",
                "features": {
                    "keywords": [
                        "需求旺盛",
                        "创新",
                        "美年健康",
                        "高质量发展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生物医药板块全线大涨，两条主线布局投资机会（附股）丨牛熊眼",
                "features": {
                    "keywords": [
                        "生物医药",
                        "全线大涨",
                        "投资机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "千亿顶流时代基金规模会否成业绩的敌人",
                "features": {
                    "keywords": [
                        "千亿顶流",
                        "时代基金",
                        "规模",
                        "业绩"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}